Experimental cancer therapy shows success in more than 70% of patients in global clinical trials


A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

Nintendo’s first clip from ‘The Super Mario Bros. Movie’ shows off the Mushroom Kingdom

Previous article

Overexpression of lncRNA MVIH may serve as a potential diagnostic biomarker in cervical cancer

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations